Studying the tumor microenvironment (TME) helps improve our understanding of cancer. Myeloid-derived suppressor cells (MDSCs) exist within the TME and maintain cancer progression. MDSCs can be used as prognostic markers and potential therapeutic targets to eliminate immunosuppressive activities and enhance antitumor immune responses.
Download this whitepaper to learn more about immunotherapy strategies including:
- Depletion of MDSC populations and infiltration
- Inhibition of MDSC recruitment and transport
- Anticytokine therapy of MDSCs